Pharmaceuticals, Biotechnology and Life Sciences
Conference Call and Webcast Scheduled for Wednesday, November 10, 2021 at 4:30 p.m. Eastern TimeREDWOOD CITY, Calif., Nov. 03, 2021…
NEWARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing…
WALTHAM, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company advancing new treatments for…
SEATTLE, Nov. 03, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that…
TYRVAYA(TM) (varenicline solution) TYRVAYA™ (varenicline solution) Nasal Spray 0.03 mg is now available at U.S. regional wholesalers for distribution to…
Phase 1 data from Gritstone-sponsored CORAL study (SARS-CoV-2 second generation vaccine utilizing self-amplifying mRNA boost) expected in early Q1 2022;…
EMERYVILLE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen” or the “Company”), a leading biofacturing company, today reported…
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer…
CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX | NASDAQ: XRTX),…
MALVERN, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and…